The pharmaceutical industry is under tremendous pressure to reduce the R&D costs, address the unmet needs, conduct the transition from producing medicines to managing outcomes, and serving the emerging markets as well as the growing patient population more effectively. The adoption of digital technologies and business models can assist the industry in addressing these challenges and managing their top-line growth while improving bottom-line efficiency.
Nexus of Transition in the Pharmaceutical Industry
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines
READ THE ENTIRE ISSUE